31 March 2020: The link to the Dynamic Dashboard is here.
The Dashboard will continue to mature its data set, expand the funders captured, its countries represented and its scope to other areas of AMR R&D. Additional user-functionality will follow soon. In the coming months, further galleries of information will be added including product pipelines and incentives.
A user guide and background information of how the information was collected can be found here.
We thank all the organisations that have provided data and invite anyone who would like to submit data to contact us.
04.02.2025
New Publication in Vaccine
Vaccines play a vital role in preventing infections and reducing antibiotic use, making them essential tools in the fight against antimicrobial resistance (AMR). Given that AMR disproportionately impacts Low- and Middle-Income Countries (LMICs), this study provides this first comprehensive analysis of global investments in bacterial vaccine research and development (R&D) in LMICs.